ADVANCING TREATMENTS FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): TRENDS AND OPPORTUNITIES
Andrew Bevan 1
Alessandra Vignola 2
Paola Figueroa 3
Sigrunn Blacoe 4
Isabella Facchini 5
1 PPD Part of Thermo Fisher Scientific, Cambridge, United Kingdom
2 PPD Part of Thermo Fisher Scientific, Wilmington, United States
3 PPD Part of Thermo Fisher Scientific, Austin, United States
4 PPD Part of Thermo Fisher Scientific, Bellshill, United Kingdom
5 PPD Part of Thermo Fisher Scientific, Munchen, Germany
Session
PP 10 Health economics / Digitalisation in GI / Education In GI / Gender and diversity (Posters)
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]